This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Not just for the prevention of heartdisease but also to reduce your risk of dying from all conditions. The relationship is simple—higher cholesterol for longer increases your risk of coronaryarterydisease 4. If you have a family history of heartdisease, this is a must-do test.
Investigators have uncovered a way to unleash in blood vessels the protective effects of a type of fat-related molecule known as a sphingolipid, suggesting a promising new strategy for the treatment of coronaryarterydisease.
Lower socioeconomic status is associated with higher rates of death from coronaryarterydisease compared to higher socioeconomic status, and more than half of the disparities can be explained by four unhealthy behaviors, according to a new study.
In addition to causing several types of cancer, human papillomavirus (HPV) appears to bring a significantly increased risk of heartdisease and coronaryarterydisease, according to a new study.
Diabetes is a predominant driver of coronaryarterydisease worldwide. This study aims to unravel the distinct characteristics of oral and gut microbiota in diabetic coronaryheartdisease (DCHD). Simultaneous.
Using an advanced artificial intelligence tool, researchers have identified rare coding variants in 17 genes that shed light on the molecular basis of coronaryarterydisease (CAD), the leading cause of morbidity and mortality worldwide.
Heartdisease remains one of the leading causes of death worldwide, often attributed to a mix of lifestyle choices, environmental factors, and genetic predispositions. Understanding the Genetic Connection to HeartDisease Your genetic makeup plays a vital role in shaping your heart health.
Coronaryarterydisease and major depression may be genetically linked via inflammatory pathways to an increased risk for cardiomyopathy, a degenerative heart muscle disease, researchers have found.
Researchers have uncovered a significant genetic connection between Alzheimer's disease (AD) and several coronaryarterydisease (CAD) related disorders and lipid classes, offering opportunities to improve health outcomes across two of the more common causes of death in Australia.
Reversing or regressing coronaryarterydisease is possible. But can coronaryarterydisease be reversed with lifestyle measures, including changes to nutrition and exercise? Subscribe now 1 Pathophysiology of CoronaryArteryDisease. Can lifestyle changes reverse coronaryheartdisease?
A common feedback I get is that people with existing coronaryarterydisease feel like it doesn’t apply to them. Arguably, applying the principles of prevention offers more bang for buck in the short term for people WITH coronaryarterydisease than those without coronaryarterydisease.
A rare variant association study using exome sequencing data was performed on a machine learning-based marker for coronaryarterydisease (CAD). Our findings help us understand how these 17 genes are involved in coronaryarterydisease. Credit: Ron Do, PhD, and Ben Omega Petrazzini, BS, at Icahn Mount Sinai.
ObjectiveThis study aims to sheds light on the correlation between urinary cadmium (Cd-U) exposure and coronaryheartdisease (CHD) and the mediating effects of serum alkaline phosphatase (ALP) based on a sample of adults in the United States.MethodsA comprehensive cross-sectional study was performed on 8,998 CHD participants who participated in the (..)
In addition to causing several types of cancer, human papillomavirus (HPV) appears to bring a significantly increased risk of heartdisease and coronaryarterydisease, according to a study being presented at the American College of Cardiology's Annual Scientific Session (ACC.25).
milla1cf Tue, 01/09/2024 - 11:32 January 9, 2024 — Cleerly , the company working to create a new standard of care for the diagnosis of heartdisease, announced the launch of Cleerly ISCHEMIA , which recently received U.S. Food and Drug Administration (FDA) 510(k) medical device clearance.
Coronaryarterydisease is caused by the retention of a cholesterol particle in the artery wall. Insulin resistance and diabetes may not ‘ cause ’ coronaryarterydisease, but they are huge accelerants. If delaying the onset of major chronic disease is your goal. Timing Matters.
Together, the two companies will work to further the development and commercialization of Medis Quantitative Flow Ratio (Medis QFR), a non-invasive approach to the assessment of coronary physiology, as part of GE HealthCare’s interventional cardiology portfolio built around the Allia Platform.
However, researchers lack efficient ways to explore how these genetic variants are molecularly connected to cardiovascular disease, limiting efforts to develop therapeutics.
Researchers at Edith Cowan University's (ECU's) Centre for Precision Health have uncovered a significant genetic connection between Alzheimer's disease (AD) and several coronaryarterydisease (CAD) related disorders and lipid classes, offering opportunities to improve health outcomes across two of the more common causes of death in Australia.
Cleerly, a digital healthcare company focused on heartdisease, has announced continued strong scientific evidence supporting the clinical utility of its products, detailing a study published online on Jan. 25, 2024 in the European Heart Journal Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2023 Dec 12:jead339.
Preventing heartdisease is possible. To prevent heartdisease, you need to know what causes it, how to measure the relevant factors and what to do about them. When we say heartdisease, what we really mean is plaque in the artery wall. You just need to know how. This Is Known As Atherosclerosis.
Does stress cause heartdisease? But What About Stress & HeartDisease? When stress is included in the risk factor profile for a future heart attack, it comes in third on the list after abnormal cholesterol and smoking 1. Stress causes heartdisease. +PS First, let’s define some terms.
The same principle applies to assessing and managing your risk of heartdisease. I am frequently asked ‘ When ’ should people start thinking about assessing their risk of heartdisease and also focusing on reducing it. Unless, of course, you do not have any interest in reducing your risk of heartdisease.
milla1cf Wed, 03/06/2024 - 18:48 March 6, 2024 — Cleerly , the company on a mission to create a new standard of care to aid in the diagnosis of heartdisease, has been granted Breakthrough Device Designation by the U.S. Food and Drug Administration ( FDA ) for its CoronaryArteryDisease ( CAD ) Staging System.
Heartdisease does not kill people. Heart attacks do. Appreciating this distinction is critical to understanding heartdisease. Heartdisease is the presence of plaque or atherosclerosis in the coronaryarteries. We want to prevent the ‘Event’ that causes our death.
If you have an early family history of heartdisease, there are specific steps you need to take to define if you have an increased risk and what to do about it. Heartdisease is the leading cause of death worldwide, and the probability of someone in your family having heartdisease is likely to be high.
Researchers have studied hundreds of elements of the built environment, including buildings, green spaces, pavements and roads, and how these elements relate to each other and influence coronaryarterydisease in people living in these neighborhoods.
With this new funding, Cleerly will continue to scale its commercial growth and clinical evidence generation, helping health care professionals improve outcomes for patients across the coronary care pathway. Barclay continued, “Cardiovascular disease is the #1 cause of death globally and costs our country $422B annually.
Understanding where you sit on this continuum is a key part of defining your future risk of heartdisease but also dementia, and many cancers. Even having one of the metabolic syndrome factors increases the risk of dying from heartdisease by 73% 4. J Am Heart Assoc. BMC Public Health 24 , 574 (2024). Circulation.
a provider of AI technology for coronaryarterydisease (CAD) management, recently introduced its new brand identity reflecting its focus on delivering clarity, precision and confidence in the prevention, diagnosisand treatment of CAD. References Centers for Disease Control and Prevention. HeartDisease Facts.
Polygenic risk scores (PRSs) are a cutting-edge tool in genetics, combining information from genetic markers across the genome to estimate a person's risk of developing certain diseases, such as coronaryarterydisease (CAD).
The majority of heart attacks occur as a result of plaque in the coronaryarteries that is not obstructive and, therefore, asymptomatic. 2 You will not know you have heartdisease by waiting for symptoms. mmol/l (130 mg/dl) or below, between 20-50% will already have coronaryarterydisease.
Research shows that chronic gum inflammation may be associated with other chronic diseases including coronaryarterydisease and diabetes.[1] DALLAS, JANUARY 16, 2024 — A patient’s oral health can be an indicator of overall health and well-being.
Cardiovascular disease is the leading cause of death worldwide. Over 80% of early heartdisease is preventable. However, most adults will start to develop advanced plaque in their coronaryarteries early in life. It kills almost twice as many people globally when compared to all cancers combined. The answer is yes.
Using an advanced artificial intelligence tool, researchers at the Icahn School of Medicine at Mount Sinai have identified rare coding variants in 17 genes that shed light on the molecular basis of coronaryarterydisease (CAD), the leading cause of morbidity and mortality worldwide.
They knew they had not been doing all the things they should do, and they were worried that heartdisease had them in its sights. The key issue when it comes to the near-term risk of a heart attack is whether you already have coronaryarterydisease and how much of it. “Am I going to be ok?”
Almost every patient we saw had advanced obstructive coronaryarterydisease. For many of these patients (but not all), their coronaryarterydisease was avoidable. To understand IF they had heartdisease or were at a high risk of heartdisease in the future. Problem Solved?
mg reduces the risk of major adverse cardiovascular events (MACE) and supports its use in the treatment of cardiovascular disease. mg)has potential to directly reduce inflammation, which plays a substantial role in the formation and progression of atherosclerotic plaque leading to heartdisease, said Matthew J. Budoff, M.D.,
Nature Reviews Cardiology, Published online: 14 November 2024; doi:10.1038/s41569-024-01099-7 Debate exists regarding the best terminology for common presentations of heartdiseases caused by epicardial and/or microvascular coronaryarterydisease with or without myocardial ischaemia.
Their findings could lead to new therapies for people with endothelial dysfunction, a type of disorder that contributes to coronaryarterydisease that may occlude with plaque and lack ability to carry sufficient blood into the heart tissue causing a heart attack.
I'm Interested In Case You Missed Them: 1 Antibody-Based Therapeutics for Atherosclerosis and Cardiovascular Diseases. 2 Dose-Response Associations of Lipid Traits With CoronaryArteryDisease and Mortality. 2021 , 22 , 5770. JAMA Netw Open. 2024;7(1):e2352572. 3 NCD Risk Factor Collaboration (NCD-RisC). 2024 Jan 14.
Heartdisease remains a leading cause of death worldwide despite advancements in medical science and healthcare. Below, we aim to debunk common myths about cardiovascular disease, providing accurate information and emphasizing the importance of treatment for heartdisease with timely interventions.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content